Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Cash flows from operating activities:
Net loss	$ 26	$ (2,220)	$ (4,829)	$ (7,388)
Adjustments to reconcile net loss to net cash provided by operating activities:
Amortization of debt discount and issuance cost			1,097	1,061
Bad debt expense (recovery)			8	(195)
(Gain) loss on settlement of liabilities			(856)	2,378
Changes in deferred tax assets and liabilities			(719)	1,243
Change in allowance for sales returns and volume rebate			191	327
Change in inventory reserve			749	(33)
Change in fair value of derivative liability	(1,660)	(41)	(1,650)	225
Shares issued for interest payment on notes payable				373
Stock compensation expense			2,062	1,859
Depreciation and amortization			4,587	3,567
Non-Cash Lease Expense			(98)
Changes in operating assets and liabilities:
Accounts receivable - trade			(13,839)	(14,560)
Inventories			2,010	37
Prepaid expenses and other assets			(1,149)	(7,365)
Accounts payable and accrued expenses			2,969	10,879
Other liabilities			9	487
Deferred revenues			2,582	2,535
Net cash used in operating activities			(6,876)	(4,570)
Cash flows from investing activities:
Business acquisitions (net of cash acquired)				(685)
Settlement of earnout obligations				(119)
Purchases of furniture and fixtures, net			(659)	(48)
Net cash used in investing activities			(659)	(852)
Cash flows from financing activities:
Proceeds from short-term debt			2,500	17,350
Principal payments on debt			(1,305)	(17,417)
Payments of fixed dividends to Series B Preferred stockholders			(631)	(317)
Proceeds from the exercise of options and warrants			57	245
Net cash provided by (used in) financing activities			621	(139)
Effect of foreign currency exchange rates			596	(462)
Net decrease in cash and cash equivalents			(6,318)	(6,023)
Cash and cash equivalents, beginning of the period			17,938	13,460	$ 13,460
Cash and cash equivalents, end of the period	$ 11,620	$ 7,437	11,620	7,437	$ 17,938
Supplemental cash flow disclosures:
Cash paid for income taxes			215	1,031
Cash paid for interest			$ 3,731	1,368
Non-cash investing and financing transactions:
Shares issued to settle accounts payable				1,626
Exercise of warrants				51
Deemed contribution - Series B Preferred				367
Deferred consideration for acquisition				537
Shares issued to convert notes payable and accrued interest				9,872
Shares issued for acquisition				403
Declared but unpaid fixed dividends on Series B Preferred Stock				$ 317